RVNC


Revance Shares Fall on Failing to Bag FDA Approval

Shares of Revance Therapeutics, Inc. (RVNC) dropped 33.

3 “Strong Buy” Healthcare Stocks With Major Catalysts Approaching

It can happen in a New York minute. We are talking about the massive gains certain healthcare stocks are able to notch in …

Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead

After several postponed decisions, Mylan Inc (MYL) has announced that it is moving forward with a Botox biosimilar development program in collaboration with …

Revance Acquires HintMD In All-Stock Deal, Analyst Praises Bold Step Forward

Silicon Valley biotech Revance Therapeutics (RVNC) has announced the signing of a definitive agreement to acquire Hint, Inc, a private company which has …

3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside

Biotech stocks require only a few select indicators to send a share price soaring, or conversely, to cause it to tumble mercilessly down …

3 Hot Biotech Stocks With 100% Street Support

For more risk-tolerant investors, biotechs are screaming buys. This space is consistently on the Street’s radar as a single catalyst such as a …

This Healthcare Analyst Pounds the Table on Revance Therapeutics Inc (RVNC)

Guggenheim’s Rohit Vanjani puts a price tag on Revance Therapeutics.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts